SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-15-000265
Filing Date
2015-03-30
Accepted
2015-03-30 15:59:45
Documents
1
Period of Report
2015-03-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ss423044_4.html 4  
1 OWNERSHIP DOCUMENT ss423044_4.xml 4 33235
  Complete submission text file 0000947871-15-000265.txt   34622
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address
SILVERSTEIN JONATHAN (Reporting) CIK: 0001171005 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 15734459

Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations